Providers at Utah's two largest healthcare systems may now treat patients with psilocybin and MDMA as part of a pilot program created by a proposal-turned-law that will take effect as early as May 1, 2024.

The program, open to providers at the University of Utah Health and Intermountain Health, will last three years. Next, the Legislature will decide whether or not to resume it.

Physicians will be allowed to administer adult patients with psilocybin or MDMA in a medical facility. Yet the bill does not specify that hospitals can use these substances for treating conditions for which they have...